GlassScriptPhysician profile
Jason C Swigert
NPI 1558550731
$10,476.48
in general payments reported to CMS, 2019-2025
59 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $1,398 · 2021: $1,614 · 2022: $1,802 · 2023: $1,315 · 2024: $1,655 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,529 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,529.22 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,438.52 | 2020-2025 | Vraylar, Ubrelvy, Linzess |
| Novartis Pharmaceuticals Corporation | $1,044.64 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $793.86 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $743.47 | 2019-2025 | |
| Novo Nordisk INC | $606.01 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $535.08 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $522.50 | 2019-2025 | Krystexxa, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $513.54 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Janssen Pharmaceuticals, INC | $301.61 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $297.99 | 2021-2022 | |
| Boston Scientific Corporation | $236.52 | 2019-2025 | Coveredge 32, General - Pain Management, Artisan |
| Sanofi-Aventis U.S. LLC | $215.39 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $204.16 | 2022 | |
| Merck Sharp & Dohme LLC | $201.37 | 2019-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Nestle Healthcare Nutrition INC. | $201.36 | 2020-2022 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $199.94 | 2019-2023 | Freestyle Libre 3 |
| Philips North America LLC | $189.10 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $171.87 | 2019-2021 | |
| Lundbeck LLC | $167.38 | 2023-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $157.19 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $148.52 | 2022-2025 | |
| Radius Health, INC. | $139.67 | 2023-2025 | Tymlos |
| Allergan, INC. | $120.98 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $108.37 | 2024-2025 | Zenpep |
| Glaxosmithkline, LLC. | $104.80 | 2020-2024 | Trelegy Ellipta, Shingrix |
| Neurocrine Biosciences, INC. | $88.21 | 2020-2021 | |
| Amarin Pharma, INC. | $86.03 | 2019-2021 | |
| Mylan Specialty L.P. | $84.69 | 2019-2024 | Yupelri |
| Dexcom, INC. | $82.51 | 2021-2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $79.17 | 2021-2025 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $56.01 | 2025 | Rexulti |
| Ibsa Pharma INC. | $53.85 | 2020-2021 | |
| Horizon Therapeutics Plc | $46.13 | 2020-2023 | Krystexxa |
| Phathom Pharmaceuticals, INC. | $34.10 | 2024 | Voquezna |
| Medtronic, INC. | $34.10 | 2024-2025 | Venaseal |
| Biohaven Pharmaceuticals, INC. | $33.88 | 2021 | |
| Alkermes, INC. | $31.73 | 2022-2023 | Lybalvi |
| Idorsia Pharmaceuticals US INC | $31.49 | 2024 | Quviviq |
| Exact Sciences Corporation | $30.43 | 2023-2024 | Cologuard Collection Kit |
| Tactile Systems Technology INC | $25.54 | 2019-2021 | |
| Viatris Specialty LLC | $24.69 | 2025 | Yupelri |
| Ironwood Pharmaceuticals, INC | $24.02 | 2019-2020 | |
| Nevro Corp. | $22.68 | 2022 | |
| Vanda Pharmaceuticals INC. | $21.96 | 2021 | |
| Lucid Diagnostics INC. | $21.06 | 2023 | |
| Xeris Pharmaceuticals, INC. | $20.82 | 2024 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $20.17 | 2024 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.62 | 2025 | Caplyta |
| Strongbridge US INC. | $18.22 | 2019 | |
| Ge Healthcare | $18.12 | 2019 | |
| Urovant Sciences INC | $17.88 | 2021 | |
| Kyowa Kirin, INC. | $15.79 | 2025 | |
| Baxter Healthcare | $14.72 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Esperion Therapeutics, INC. | $14.17 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $13.49 | 2022 | |
| Eisai INC. | $12.51 | 2021 | |
| Sumitomo Pharma America, INC. | $7.56 | 2023 | Gemtesa |
| Insightec,INC | $7.29 | 2024 | Exablate |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Swigert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.